Polyrizon Ltd. Ordinary Shares (PLRZ) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.67
• Market Cap: $14.10M
• EPS: $-1.22
• 52-Week High: $2235.00
• 52-Week Low: $2.88

Market Sentiment

Polyrizon Ltd. Ordinary Shares currently has a Bullish sentiment score of 0.39.

About Polyrizon Ltd. Ordinary Shares

Polyrizon Ltd. is a pioneering biotechnology firm headquartered in Ra'anana, Israel, dedicated to advancing medical device hydrogels specifically tailored for nasal spray applications. By harnessing its proprietary technology, Polyrizon aims to enhance drug delivery mechanisms, addressing significant unmet medical needs and transforming therapeutic approaches in nasal treatments. With a strong commitment to innovation, the company seeks to improve patient outcomes in the healthcare sector and...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Polyrizon Ltd. Ordinary Shares and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PLRZ pay dividends?

Polyrizon Ltd. Ordinary Shares (PLRZ) does not currently pay a regular dividend.

What is PLRZ's market cap?

Polyrizon Ltd. Ordinary Shares (PLRZ) has a market capitalization of $14.10M with a current stock price of $13.67.